Skip to main content

Table 6 Types of DRPs identified and level of intervention for each DRPs between two groups

From: Impact of medication therapy management (MTM) service model on multi-morbidity (MMD) patients with hypertension: a pilot RCT

DRPs Classification

At the initial phase of admission

In the twelfth month after discharge

Confirmed as resolved, n (%)

Intervention group

Control group

Intervention group

Control group

Intervention group

Control group

(n = 51)

(n = 50)

(n = 51)

(n = 50)

(n = 51)

(n = 50)

Indication

Drug without indication

16(18.8)

13(15.5)

5(23.8)

10(17.9)

11(17.2)

3(10.7)

Untreated indication

6(7.1)

8(9.5)

1(4.8)

5(8.9)

5(7.8)

3(10.7)

Effectiveness

Different drugs need to be selected

13(15.3)

11(13.1)

5(23.8)

8(14.3)

8(12.5)

3(10.7)

Underdose

4(4.7)

3(3.6)

0(0.0)

1(1.8)

4(6.3)

2(7.1)

Safety

Adverse drug reaction

18(21.2)

22(26.2)

5(23.8)

16(28.6)

13(20.3)

6(21.4)

Overdose

7(8.2)

8(9.5)

1(4.8)

3(5.4)

6(9.4)

5(17.9)

Compliance

Non-adherence

21(24.7)

19(22.6)

4(19.0)

13(23.2)

17(26.6)

6(21.4)

Total

85(100.0)

84(100.0)

21(100.0)

56(100.0)

64(100.0)

28(100.0)